ABSTRACT
INTRODUCTION
Burns is a global public health problem, accounting for an estimated 180,000 deaths annually. The majority of these occur in low-and middle-income countries and almost two-thirds occur in the WHO African and Southeast Asia Region. Over 10 lakh people are moderately or severely burnt every year in India. [1] Second degree or partial thickness burn patients are targeted as nonfatal burns are the leading cause of morbidity and prolonged hospitalization. Burns are among the leading causes of disability-adjusted life years (DALYs) lost in low-income and middle-income countries. Apart from the cost of treatment indirect costs, such as lost wages, prolonged care for scars and deformities, emotional trauma, and commitment of family resources, also contribute to the socioeconomic impact.
Nanocrystalline silver gel versus conventional silver sulfadiazine cream as topical dressing for second-degree burn wound: A clinicopathological comparison
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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. The final aim of burn management and therapy is to minimize pain and thereby reducing the chance of anxiety and depression, [2] to prevent infection, to promote early epithelialization as well as healing of wound and betterment of functional and esthetic after effects. The use of topical agent has been fundamental in that regard and has helped to improve the survival of patients with major burns and to minimize the incidence of burn wound sepsis, a leading cause of mortality and morbidity in these patients. One of the strategies that have gained attention is the use of noble metal antimicrobials, the most prevalent of which is silver. The delivery systems available, often in the form of a salt, have been the limiting factor to the successful biological use of this noble metal.
Over the past 40 years, silver sulfadiazine (SSD) has become a very popular antimicrobial silver delivery system. All kinds of combinations of sulfa drugs with silver were tested in vitro, but SSD appeared to be the most effective [3] and therefore used as a conventional dressing agent in burn wounds. However, development of bacterial resistance and impaired reepithelialization has been described. Bone marrow toxicity observed with SSDs primarily due to the propylene glycol component. Other side effects include argyria, hepatic, and renal toxicity. [4] [5] [6] [7] These adverse effects demand a new therapy options for better burn wound management.
Advances in the field of nanotechnology helped us to provide a new form of silver delivery system and have markedly improved the biologic value of silver. Nanosilver particles have no local or systemic toxicity and do not impair healing. Smaller the particle size of silver, greater contact with wound surface area, thus increasing bioactivity and silver solubility. These advances in crystal chemistry will likely have a dramatic impact on the microbiology, as well as the biology of wound healing and control of inflammation.
The aim of this study is to compare the overall effect (clinical, microbiological, and histological) of topical application of 1% SSD and nanocrystalline silver gel dressing in second-degree burn patients.
MATERIALS AND METHODS
The study was carried out in a tertiary care burn unit, in Kolkata, from January 2013 to December 2014. The study was approved by the Institutional Ethical Committee. A total of 90 patients aged between 10 and 60 years were selected for the study. 45 patients assigned for each nanocrystalline-silver (nano-Ag) and 1% SSD group randomly.
Inclusion criteria -Patients with second-degree thermal burn injury involving 10%-30% of the total body surface area (TBSA) involvement attending within 24 h and those patients who gave an informed consent. Exclusion criteria -Patients who refused to participate in the study or not fulfilling the inclusion criteria, pregnants, or those suffering from other medical illnesses.
In outpatient department or after hospitalization, patients are subjected to clinical assessments regarding degree [8] [9] [10] and extent of burn. Written informed consent obtained and clinical photographs taken from those who meet the inclusion criteria. Initial burn management was started according to the principles of ABCDEF -It denotes A-Airway control, B-Breathing, C-Circulation, D-Neurological Disability, E-Environment control, F-Fluid Resuscitation. [11] As the wound healing time, depends on TBSA burnt and depth of tissue injury, we distributed the patients in two groups on TBSA burnt (10%-20% and >20%-30%). We further divided them into subgroups on depth of involvement (second-degree superficial and deep dermal burn).
After exposing the burn wound, the involved and its adjacent area washed properly with normal saline to remove all dirt, soot, debris, following which all blisters were deroofed, dead epithelium was removed as far as possible. Now, a dilute povidone-iodine solution was applied and finally, washed again with sterile normal saline solution. Having selected randomly SSD cream and nano-Ag gel applied over the control group and test group, respectively. We assumed all acute burn wound are sterile. Systemic broad-spectrum antibiotics given to all on day 0 and changed according to pus culture report which was sent on 3 rd postadmission day; bacterial culture and sensitivity determinations were made from the swabs taken from the surface of the wounds; hemoglobin, nutrition, hydration, and dyselectrolytemia was corrected, and hence, optimization of internal environment and external environment kept equal for all patients.
Nano-Ag gel applied in the test group and covered by sterile gauze (inner layer), and gamjee (outer layer) and dressings were changed every alternate day until the wound is healed. SSD cream was applied in the control group and then covered with sterile dressing, and the frequency of dressing change was kept the same for the two groups until the wound was healed. The involved and surrounding area of wound was photographed at regular interval.
A histological study was done only in deep dermal burn cases, as these wounds granulates and heals with scarring.
Only, clinically deep dermal burn patients were biopsied on day 3 of burn injury, for the proper assessment of depth of injury. Initially, by clinical estimation of depth, biopsy was done in 59 patients, of those only 48 cases who fulfilled the criteria of deep dermal burn were included (SSD and nano-Ag applied in 25 and 23 patients, respectively) for further histological study. Tissues were also taken on day 15, from granulation tissue and after 12 weeks, from the healed wound in both the groups. All tissues were taken under local anesthesia. Biopsies were taken from at least three representative areas of the wound surface to include 3 mm depth of the wound and a 3 mm area of normal skin. All of them were fixed in buffered formalin, sectioned, and stained with hematoxylin and eosin. [12] The sections were viewed and photographed at ×40, ×100, and ×400 magnifications.
Following parameters are evaluated to assess the efficacy of nano-Ag gel dressing over SSD cream dressing:
• Pain perception assessed using visual analog scale [13] on day 7, 14, and 21
• Assessment of microbial flora • Antimicrobial efficacy of the agents to prevent colonization • Degree of wound discharge (Amount of exudates) • Appearance of healthy granulation for deep dermal burn • 50% reepithelialization and probability of complete reepithelialization by 2 and 4 weeks depending on the depth of burn • Actual duration of wound healing • Histological assessment.
The study was a prospective study. Sample randomization was done by computer software. SSD 1% cream used was supplied by hospital store. Nano-Ag gel was prepared aseptically and packed in sterile container [ Figure 1 ] in the departmental laboratory. [14] All the data gathered summarized and statistical analysis has been done by GraphPad Prism version 5 (Developer: GraphPad Software, Inc., California, USA). The analysis was two-tailed and P < 0.05 was considered statistically significant.
RESULTS
A total of 90 patients were recruited for the study purpose. Demographic and average age distribution of the patients for the study is depicted in Tables 1 and 2 , respectively. There was no statistically significant difference between both the groups in respect of age, gender, and extent of TBSA involvement.
The intensity of pain is observed more in the cases of deep dermal burns and in initial week. Results were compared using two-way ANOVA test which showed the intensity of pain felt is significantly lesser in nano-Ag group than in patients of SSD dressing group throughout 1 In superficial dermal burn patients, majority of the patients had small amount of exudates, whereas none of them had heavy exudates. However, in deep dermal group, 13 patients (52%) in the SSD group had heavy exudates whereas similar percentage in the nano-Ag group had small exudates Table 3 .
Out of 90 patients, 48 were culture positive and mostly in deep dermal burns. Nano-Ag group showed less number of culture-positive cases, and it is statistically significant (P = 0.0369) as shown in Table 4 . Among 48 positive cases, 84 colonies were present. More than 50% of cases are positive for Pseudomonas. Figure 3 shows all types of microorganisms are more effectively killed in nano-Ag group compared to the SSD group except for Klebsiella and Proteus.
Usually, superficial dermal burn does not need the formation of granulation for healing unless complicated by patients immunity profile. The appearance of healthy granulation tissue in respect of days was only studied in deep dermal burns and showed significant less time (P = 0.0009) in nano-Ag group (21.69 ± 7.16) compared to SSD (29.80 ± 9.04) [ Figure 4 ].
In deep dermal burn, statistically significant number of patients in nano-Ag group achieved 50% epithelialization by 4 weeks (P = 0.020), on the other hand, majority of the patients could not achieve complete epithelialization by 4 weeks in both study arms and are not statistically significant (P = 0.06) [ Table 5 ]. When Log-ranked, Kaplan-Meier plots depict [ Figure 5 ] statistically significant result in the time trend (in the two study arms) toward the probability of 50% epithelialization (P = 0.0018) and probability of complete epithelialization (P = 0.0380). Similarly, in superficial dermal burn patients, 50% epithelization (P = 0.055) and complete epithelization (P = 0.190) in 2 weeks assessed and it is found that majority of these patients could not achieve complete epithelization by 2 weeks in both the study groups [ Table 6 ]. When log-ranked, Kaplan-Meier plots depict statistically significant result in the time trend (in the two study arms) toward the probability of 50% epithelialization (P = 0.0221); however, the probability of complete epithelialization (P = 0.101) was not significant statistically.
As depicted in Table 7 , complete wound healing time was less in nano-Ag group be it deep dermal or superficial dermal. However, statistically significant results obtained only in deep dermal burns in both 10%-20% TBSA (P = 0.024) group and >20%-30% TBSA (P = 0.029) group. Photographs of a patient with deep dermal burn treated with nano-Ag gel dressing in various stages of wound healing as shown in Figure 6a -c.
Histopathology findings
On day 3, the biopsied tissue from both the groups showed acute inflammatory exudate intermixed with necrotic debris and red blood cells up to the papillary dermis or both papillary and reticular dermis (depth assessment). On day 15, majority of the samples in the nano-Ag group showed the presence of well-formed granulation tissue without stromal edema, and acute inflammatory cell infiltrate whereas the SSD group showed the presence of both [ Figures 7 and 8 ].
At the margin of the wound, partial epithelialization was observed in few specimens of nano-Ag group. The nano-Ag group in 12 weeks showed complete epithelialization with normal maturation, normal vascularization in the papillary dermis, and preservation of dermal appendages in varying amount with minimal inflammatory cell infiltration. The SSD group also showed complete healing at 12 weeks with predominantly hyperplastic overlying epidermis, underlying fibrovascular dermal stroma with deposition of thin fibrillary collagen in the papillary and reticular dermis [ Figures 9 and 10 ]. These histological findings corroborate well with clinical assessment. Fisher's exact test applied to determine the statistical significance between the study groups. SSD: Silver sulfadiazine, Nano-Ag: Nanosilver Fisher's exact test applied to determine the statistical significance between the study groups. SSD: Silver sulfadiazine, NS: Not significant DISCUSSION Silver as a topical antimicrobial agent has been used for many centuries. A wide range of wound dressings that contain elemental silver or a silver-releasing compound has been developed for primary burn management. Dr. Charles Fox introduced SSD cream in 1970, [15] and since then has been an important part of burns management. Among all kinds of sulfa drugs combinations with silver, silver sulfadiazine emerged as [3] the "gold standard" topical agent for burn wounds. [16] This silver complex acts on the bacterial wall, and its effectiveness can be explained by the relatively strong bonding of silver sulfadiazine to DNA [17] which differs from that of silver nitrate or other silver salts. [17, 18] However, the use of silver dressings in wound care has recently been faced with considerable challenges as it may slow the process of healing [19] can develop bacterial resistance [20] [21] [22] and has been reported with bone marrow toxicity. Mann-Whitney U-test used to ascertain the P value for comparison between the groups. SD: Standard deviation, Nano-Ag: Nanosilver, SSD: Silver sulfadiazine
With the advent of nanotechnology ("nano" signifies one-billionth [10 −9 ] ) perhaps the most unique form of silver developed for wound dressings is nanocrystalline silver, which differs in both physical and chemical properties from microcrystalline or macrocrystalline silver and from silver salts. [23] This is, in part, related to the increase in grain boundary atoms as a percentage of the total atoms in the material, which is due to the small crystal size. These grain boundaries, according to Birringer, [24] may represent a third state of solid matter. There is a marked increase in surface area for water to reaction with silver in the nanocrystalline form. High surface-to-volume ratio makes silver nanoparticles more effective even at very low concentration, thus reduces the chance of toxicity. Nanocrystalline silver is a metastable, high-energy form of elemental silver. Normal silver placed in water will not dissolve, but nanocrystalline silver in aqueous system may exist in both Ag + and/or Ag 0 forms, whereas other silver sources release only Ag + . [23, 25, 26] The nature of the solute also affects the biological activity of silver. In complex organic biological fluids, continuous concentrations of silver >50 ppm and as high as 60.5 ppm [20] are needed to kill microbes. This difference in the dissolution properties of nanocrystalline silver dressings appears to alter the biological character of the solution including both antimicrobial and anti-inflammatory activities. [23] When the ions in the dressing-wound bed interface are depleted, the equilibrium shifts and more Ag + ion and Ag 0 are released, thus producing a sustained, steady supply of active silver. [27] Moreover, the use of SSD cream results in the formation of a pseudoeschar and can withdraw fluid from this wound surface. Whereas, nanocrystalline silver delivery maintains moisture layer on the wound surface. Advantages of a moist wound dressing include decrease in surface desiccation and eschar formation, increase in local growth factor production, activation of surface proteases to remove devitalized tissue, decreased surface inflammation, enhanced wound surface immune defenses, increased rate of angiogenesis and fibroblast proliferation, increased proliferation, and migration of epithelial cells along thin water layer.
Typically, the wound repair process involves steps that include inflammation around the site of injury, angiogenesis and the development of granulation tissue, repair of the connective tissue and epithelium, and ultimately remodeling that leads to a healed wound. One event that impedes wound healing is colonization of the wound bed by microorganisms. [28, 29] In addition to the production of a variety of toxins and proteases, the presence of microorganisms in a wound bed may also lead to a prolonged inflammatory response. The host inflammatory response is remarkably effective at eliminating the invading microbial population, but that same process, over time, may also damage the surrounding tissues. [28] This is evidenced by the fact that wounds associated with a heavy bacterial burden often show healing failure. [30] Nanocrystalline silver dressings have been demonstrated as effective antifungal agents, [31] have a broad antibacterial effect on a range of Gram-negative and Gram-positive bacteria and antibiotic-resistant bacteria strains, [32] thus decrease the incidence of infections that delay wound healing. [31] It also has anti-inflammatory effects [30] (reduced local matrix metalloproteinase levels and enhanced cellular apoptosis) [33] on wounds and facilitating the early phases of wound healing. Our study also reflects decrease colonization, acceleration of re-epithelialization, and thus reduction of wound healing time corresponding to other studies [14, [34] [35] [36] and thus indirect evidence of anti-inflammatory effect of nano-Ag dressing.
Pain remains the primary concern to the burn patient which is associated with initial injury and necessary daily care (procedural pain) that follows and remains largely been undertreated. [37] [38] [39] In this study, we found that nano-Ag gel is a better alternative as dressing material regarding relieving pain.
In this study, we did not come across any kind of clinically detectable adverse effects in both the groups.
The histological study revealed that pathological process in each of the subgroups was similar but the time frame differs. Nano-Ag gel dressing group achieved early and quick transition of the healing cycle as compared to SSD dressing group owing to decrease microbial load, attenuating inflammatory process. Moreover, clinically, it is seen that prolonged conservative treatment with SSD longer than 3 weeks, especially in younger age group, usually results in healing with hypertrophic or atrophic scars. [17, 40] In this study, we found that the final esthetic outcome of the healed area is far more superior in nano-Ag gel dressing group and also evidenced by histological study.
CONCLUSIONS
In this study, we were able to discover the multifaceted benefits of nanocrystalline silver gel dressings. By eliminating toxic complexes, it decreases pain and reduces bacterial load and thereby local inflammation. It also reduces exudates formation and thereby frequency of pain provoking dressing can be lessened. Overall, it has very much positive effect on wound healing and final outcome, further confirmed by histopathological study. This study reflects that in comparison to SSD, nano-Ag is able to maintain an undisturbed optimum healing environment in second-degree burn wound. Further studies regarding cost effectiveness and long-term follow-up will decide whether it is the appropriate time to consider nano-Ag gel as the "gold standard" dressing material.
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